COVID-19 and Toll-Like Receptor 4 (TLR4): SARS-CoV-2 May Bind and Activate TLR4 to Increase ACE2 Expression, Facilitating Entry and Causing Hyperinflammation
Causes of mortality from COVID-19 include respiratory failure, heart failure, and sepsis/multiorgan failure. TLR4 is an innate immune receptor on the cell surface that recognizes pathogen-associated molecular patterns (PAMPs) including viral proteins and triggers the production of type I interferons...
Saved in:
Main Authors: | Mohamed M. Aboudounya (Author), Richard J. Heads (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2021-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Toll-Like Receptor 4 (TLR4) and AMPK Relevance in Cardiovascular Disease
by: Haleh Vaez, et al.
Published: (2023) -
Phytochemicals targeting Toll-like receptors 4 (TLR4) in inflammatory bowel disease
by: Wenbin Dai, et al.
Published: (2022) -
The Role of TLR2, TLR4, and TLR9 in the Pathogenesis of Atherosclerosis
by: Mohsin H. K. Roshan, et al.
Published: (2016) -
TLR2 and TLR4 in Ischemia Reperfusion Injury
by: F. Arslan, et al.
Published: (2010) -
Neutrophil, TLR2, and TLR4 expression in newborns at risk of sepsis
by: Ari Yunanto, et al.
Published: (2013)